What Verve Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Gv 2017 GP, L.l.c. | 10% owner | Jul 25 | Tender Offer · U | −1,800,000 | — | — | 0 |
| Gv 2017 GP, L.l.c. | 10% owner | Jul 25 | Tender Offer · U | −4,260,047 | — | — | 0 |
| Gv 2017 GP, L.l.c. | 10% owner | Jul 25 | Tender Offer · U | −6,108,442 | — | — | 0 |
| Dorval Allison | Chief Financial Officer | Jul 25 | Tender Offer · U | −13,280 | — | — | 0 |
| Yeshwant Krishna | Director | Jul 25 | Tender Offer · U | −1,800,000 | — | — | 0 |
| Yeshwant Krishna | Director | Jul 25 | Tender Offer · U | −4,260,047 | — | — | 0 |
| Yeshwant Krishna | Director | Jul 25 | Tender Offer · U | −6,108,442 | — | — | 0 |
| Kathiresan Sekar | Chief Executive Officer | Jul 25 | Tender Offer · U | −240,997 | — | — | 0 |
| Kathiresan Sekar | Chief Executive Officer | Jul 25 | Tender Offer · U | −110,997 | — | — | 0 |
| Kathiresan Sekar | Chief Executive Officer | Jul 25 | Tender Offer · U | −348,431 | — | — | 0 |
| Politi Jason | Chief Technical Ops. Off. | Jul 25 | Tender Offer · U | −16,405 | — | — | 0 |
| Ashe Andrew D. | See Remarks | Jul 25 | Tender Offer · U | −348,828 | — | — | 0 |
| Adelman Burt A | Director | Jul 25 | Tender Offer · U | −428,326 | — | — | 0 |
| Lister Troy | Chief Scientific Officer | Jul 25 | Tender Offer · U | −6,952 | — | — | 0 |
| Nickerson Joan | Chief Administrative Officer | Jul 25 | Tender Offer · U | −17,420 | — | — | 0 |
| Dorval Allison | Chief Financial Officer | Apr 02 | Open-market sale · S | −3,350 | $4.15 | −$13.9K | 13,280 |
| Kathiresan Sekar | Chief Executive Officer | Apr 02 | Open-market sale · S | −9,822 | $4.15 | −$40.8K | 346,686 |
| Lister Troy | Chief Scientific Officer | Apr 02 | Open-market sale · S | −2,189 | $4.15 | −$9.08K | 6,952 |
| Politi Jason | Chief Technical Ops. Off. | Apr 02 | Open-market sale · S | −3,235 | $4.15 | −$13.4K | 14,226 |
| Nickerson Joan | Chief Administrative Officer | Apr 02 | Open-market sale · S | −2,777 | $4.15 | −$11.5K | 17,420 |
Loading...
